NASDAQ · NXL
Nexalin Technology, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NXL: Nov 13, 2026
Nexalin Technology, Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-2.91. The reported EPS for the same quarter last year was $-3.9.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-2.91 | $-2.91 | $-2.91 | 1 |
| Dec 2026 | $-2.34 | $-2.34 | $-2.34 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Quiver Quantitative- RTTNews · Oct 8, 10:09 AM EDTNexalin Technology Regains Compliance With Nasdaq Minimum Bid Price Requirement; Stock Down(RTTNews) – Nexalin Technology, Inc. (NXL) announced that it received written confirmation from Nasdaq stating that it has regained compliance with the minimum bid price requirement.
- RTTNews · Sep 3, 12:23 PM EDTNexalin Reports New Cognitive Improvements In Alzheimer's Analysis, Plans U.S. Pilot Study(RTTNews) – Nexalin Technology, Inc. (NXL), announced results from a secondary analysis of data from its randomized, sham-controlled clinical trial of the Gen-2 SYNC DIFS device in patients with mild Alzheimer's disease.
- RTTNews · Aug 27, 7:48 AM EDTNexalin Announces 1-for-30 Reverse Stock Split; Stock Down(RTTNews) – Nexalin Technology, Inc. (NXL), a developer of non-invasive neurostimulation medical devices, announced that its board of directors has approved a 1-for-30 reverse stock split of its common stock to ensure continued compliance with Nasdaq's minimum bid-price requireme
- RTTNews · Jun 10, 10:04 AM EDTNexalin's Neurostimulation Trial Shows 77.8% Anxiety Response Rate In Brazil; Stock Up(RTTNews) – Nexalin Technology, Inc. (NXL), a developer of non-invasive Deep Intracranial Frequency Stimulation (DIFS), announced positive results from an eight-week clinical trial evaluating its 15 mA, 77.5 Hz neurostimulation protocol in adults with generalized anxiety disorder
- RTTNews · May 22, 10:47 AM EDTWeekly Buzz: GH Wins FDA Nod; NMPA Green Lights HCM; MDT To Acquire SPR ; BIIB HALTS BIIB112(RTTNews) – This week's biotech landscape saw regulatory approvals across the U.S., Canada, and China, alongside collaborations, acquisitions, program halts, and positive data readouts spanning multiple therapeutic areas, including severely calcified coronary artery disease, Wils
- RTTNews · May 19, 9:24 AM EDTNexalin Acquires AI Health Platform Ahead Of HALO Clarity Pivotal Trial(RTTNews) – Nexalin Technology Inc. (NXL), a developer of non-invasive neurostimulation devices, announced the acquisition of PONM Inc. from GreenLight Ventures. PONM is the digital health platform supporting Nexalin's HALO Clarity program and Nexalin NeuroCare virtual clinic.
- RTTNews · Apr 23, 5:30 AM EDTNexalin Enters Agreement With Lindus Health To Advance Pivotal Clinical Trial Of HALO Clarity Device(RTTNews) – Nexalin Technology, Inc. (NXL), which develops neurostimulation products, announced it has entered into agreements with Lindus Health, an Accountable Research Organisation (ARO), to advance its planned pivotal clinical trial evaluating the HALO Clarity device for the
- RTTNews · Apr 15, 2:41 PM EDTNexalin Advances FDA Alzheimer's Strategy With Landmark Meetings; Stock Up(RTTNews) – Nexalin Technology, Inc. (NXL) announced progress in its U.S. regulatory pathway for Alzheimer's disease following a series of high-level meetings with the U.S. Food and Drug Administration (FDA) and international experts.
- RTTNews · Feb 24, 9:09 AM ESTNexalin Launches Pivotal HALO Clarity Trial To Support Planned FDA Submission For Insomnia(RTTNews) – Nexalin Technology, Inc. (NXL) is advancing its HALO Clarity program with the initiation of a pivotal clinical trial designed to support a planned de novo submission to the U.S. FDA for the treatment of moderate to severe insomnia.
- RTTNews · Feb 3, 10:51 AM ESTNexalin Expands Peer-Reviewed Evidence For DIFS Non-Invasive Brain Stimulation(RTTNews) – Nexalin Technology, Inc. (NXL) has highlighted a growing body of peer-reviewed neuroimaging research that reinforces its Deep Intracranial Frequency Stimulation (DIFS) technology as a leader in evidence-based, non-invasive brain stimulation. The findings underscore th
- RTTNews · Aug 1, 8:47 AM EDTNexalin Technology Appoints Justin Van Fleet As CFO(RTTNews) – Nexalin Technology, Inc. (NXL) announced Friday the appointment of Justin Van Fleet as Chief Financial Officer, effective August 1, 2025.
- Quiver Quantitative · May 28, 10:10 AM EDTNexalin Technology, Inc. to Host Investor Webinar Showcasing Innovative Neurostimulation Advances on June 3, 2025Nexalin Technology invites investors to a June 3 webinar on innovative mental healthcare technology and business updates.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Nexalin Technology, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.